Could #cancer metabolism reveal a weakness in #ESCC?
This study identifies NT5E-driven pyrimidine metabolism as a therapeutic target and shows that icaritin suppresses ESCC by promoting NT5E degradation. #MetabolomicProfiling
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...